Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program by Nora Penzel, Pablo Polosecki, Jean Addington, Celso Arango, Ameneh Asgari-Targhi, Tashrif Billah, Sylvain Bouix, Monica E. Calkins, Dylan E. Campbell, Tyrone D. Cannon, Eduardo Castro, Kang Ik K. Cho, Michael J. Coleman, Cheryl M. Corcoran, Dominic Dwyer, Sophia Frangou, Paolo Fusar-Poli, Robert J. Glynn, Anastasia Haidar, Michael P. Harms, Grace R. Jacobs, Joseph Kambeitz, Tina Kapur, Sinead M. Kelly, Nikolaos Koutsouleris, K. R. Abhinandan, Saryet Kucukemiroglu, Jun Soo Kwon, Kathryn E. Lewandowski, Qingqin S. Li, Valentina Mantua, Daniel H. Mathalon, Vijay A. Mittal, Spero Nicholas, Gahan J. Pandina, Diana O. Perkins, Andrew Potter, Abraham Reichenberg, Jenna Reinen, Michael S. Sand, Johanna Seitz-Holland, Jai L. Shah, Vairavan Srinivasan, Agrima Srivastava, William S. Stone, John Torous, Mark G. Vangel, Jijun Wang, Phillip Wolff, Beier Yao, Alan Anticevic, Daniel H. Wolf, Hao Zhu, Carrie E. Bearden, Patrick D. McGorry, Barnaby Nelson, John M. Kane, Scott W. Woods, René S. Kahn, Martha E. Shenton, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Guillermo Cecchi, Ofer Pasternak

Get full text